- Home
- RELY vs CORT Comparison
RELY vs CORT Comparison
Compare RELY & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELY | CORT |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.7B |
| IPO Year | 2021 | 2001 |
Fundamental Metrics
Financial Performance| Metric | RELY | CORT |
|---|---|---|
| Price | $17.12 | $41.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $24.13 | ★ $96.50 |
| AVG Volume (30 Days) | ★ 2.5M | 1.9M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 263.16 | N/A |
| EPS | 0.31 | ★ 0.82 |
| Revenue | ★ $1,635,147,000.00 | $761,407,000.00 |
| Revenue This Year | $21.89 | $26.08 |
| Revenue Next Year | $19.17 | $31.04 |
| P/E Ratio | $54.44 | ★ $51.08 |
| Revenue Growth | ★ 29.37 | 12.79 |
| 52 Week Low | $12.08 | $28.66 |
| 52 Week High | $24.63 | $91.00 |
Technical Indicators
Market Signals| Indicator | RELY | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 62.54 | 62.11 |
| Support Level | $16.75 | $32.95 |
| Resistance Level | $17.81 | $47.06 |
| Average True Range (ATR) | 0.60 | 2.79 |
| MACD | 0.12 | 0.56 |
| Stochastic Oscillator | 100.00 | 52.24 |
Price Performance
Historical ComparisonAbout RELY Remitly Global Inc.
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated from transaction fees charged to customers, and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.